‌

US Patent 11339190 Peptides for the treatment of covid-19

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Rush University Medical Center (company)

Current Assignee

Rush University Medical Center (company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

May 24, 2022

Patent Application Number

17133035

Date Filed

December 23, 2020

Patent Citations

US Patent 10214592 Protein assay method specific to TRACP-5b (tartrate resistant acid phosphatase 5b)

Patent Citations Received

US Patent 11667678 Peptides for the treatment of COVID-19

0

Patent Primary Examiner

CPC Code

Compositions for inhibiting the binding between ACE2 and SARS-CoV-2 spike S1 are disclosed. Methods of treating COVID-19 are disclosed. Methods of making an in vivo model of COVID-19 are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11339190 Peptides for the treatment of covid-19

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.